We serve 2-[4-(cyclopropanecarbonyl)phenyl]-2-methylpropanoic acid CAS:162096-54-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 4-(Cyclopropylcarbonyl)-α,α-dimethylbenzeneacetic Acid
CAS.NO:162096-54-0
Synonyms:
2-[4-(cyclopropanecarbonyl)phenyl]-2-methylpropanoic acid
Molecular Formula: C14H16O3
Molecular Weight:232.27500
Physical and Chemical Properties:
Density:1.213 g/cm3
Boiling point: 399.255ºC at 760 mmHg
Melting point: /
Flash point: 209.4±19.7 °C
Refractive index: 1.576
Specification:
Appearance: Off white to slight yellow solid
Purity:≥98%
Moisture Content: ≤0.5%
Impurity: ≤0.5%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Fexofenadine hydrochloride CAS:138452-21-8
Intermediates of Fexofenadine CAS:83799-24-0
Contact us for information like 4-(Cyclopropylcarbonyl)-α,α-dimethylbenzeneacetic Acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[4-(cyclopropanecarbonyl)phenyl]-2-methylpropanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[4-(cyclopropanecarbonyl)phenyl]-2-methylpropanoic acid Use and application,2-[4-(cyclopropanecarbonyl)phenyl]-2-methylpropanoic acid technical grade,usp/ep/jp grade.
Related News: Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.2-Amino-6-methylheptane hydrochloride manufacturer Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.1-Bromo-8-iodonaphthalene supplier Delta moved the date up after the US State Department warned that people should not travel to China due to concerns about the spread of coronavirus, which was first discovered in Wuhan, Hubei province, in December.4-Difluoromethoxy-3-Hydroxybenzaldehyde vendor Delta moved the date up after the US State Department warned that people should not travel to China due to concerns about the spread of coronavirus, which was first discovered in Wuhan, Hubei province, in December.The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).